From molecule to patient: innovation economics & regulatory barriers in Russian pharma – interview with Mikhail Tsyferov In the new episode…Open in Telegram ↗
What works best
Top posts by engagement and laggards — to see what to repeat and what to drop from rotation.
⚡️Wildberries bought 'Eapteka'. Sources from 'Free Cash' were right. RWB Group acquired a majority stake in the online pharmacy…Open in Telegram ↗
Tiny Antarctic sea creatures may help treat melanoma. 🟢To find out, researchers from the University of South Florida…Open in Telegram ↗
Health Ministry expands list of orphan diseases. ▶️Two diseases added to new edition: 🔘desmoid fibromatosis — a rare…Open in Telegram ↗
Roadmap approved to improve access to narcotic pain relief. 🟢The Russian Government approved an action plan…Open in Telegram ↗
Court ordered Bryansk health dept to pay 69M rubles for medicines for beneficiaries. 🟢Bryansk Region Arbitration Court upheld the claim of GUP…Open in Telegram ↗
Hormone sales market sees sudden growth ♦️According to a large-scale study by Kommersant Healthcare — commercial sales and…Open in Telegram ↗
Despite multi-million losses, NCSO enters pharma distribution. National Center for Standard Samples licensed to…Open in Telegram ↗